These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18217908)

  • 1. Cyclosporine pharmacokinetics and blood pressure responses after conversion to once-daily dosing in maintenance liver transplant patients.
    Kovarik JM; Villamil F; Otero A; Levy G; Lynch S; Cillo U; Fischer L; Nashan B; Pollard S; De Carlis L
    Clin Transplant; 2008; 22(1):68-75. PubMed ID: 18217908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching monitoring of emulsified cyclosporine from trough level to 2-hour level in stable liver transplant patients.
    Langers P; Cremers SC; den Hartigh J; Veenendaal RA; ten Hove WR; Ringers J; Lamers CB; van Hoek B
    Liver Transpl; 2004 Feb; 10(2):183-9. PubMed ID: 14762854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of cyclosporine C2 monitoring in pediatric heart transplant recipients.
    Hmiel SP; Canter C; Shepherd R; Lassa-Claxton S; Nadler M
    Pediatr Transplant; 2007 Aug; 11(5):524-9. PubMed ID: 17631021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled trial of C0- Vs C2-guided therapeutic drug monitoring of cyclosporine in stable heart transplant patients.
    Mathias HC; Ozalp F; Will MB; Borland W; Payne C; Kerr M; Lockhart J; Murday AJ
    J Heart Lung Transplant; 2005 Dec; 24(12):2137-43. PubMed ID: 16364862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine dose reduction in stable renal transplant patients with high C2 level: simplified method of single C2 measurement and individualization of C0 target.
    Higgins RM; Kanji H; Hernon M; Harrison P; Lam FT; Kashi SH
    Transpl Int; 2005 Jul; 18(7):806-10. PubMed ID: 15948859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between cyclosporine concentrations at 2 hours post-dose and clinical outcomes in de novo lung transplant recipients.
    Akhlaghi F; Gonzalez L; Trull AK
    J Heart Lung Transplant; 2005 Dec; 24(12):2120-8. PubMed ID: 16364860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving adequate cyclosporine exposure in liver transplant recipients: a novel strategy for monitoring and dosing using intravenous therapy.
    Lück R; Böger J; Kuse E; Klempnauer J; Nashan B
    Liver Transpl; 2004 May; 10(5):686-91. PubMed ID: 15108262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation Between C2 and AUC(0-4) in Renal Transplant Patients Treated With Diltiazem.
    Aros CA; Schneider HO; Flores CA; Ardiles LG; Alruiz PA; Jerez V; Mezzano SA
    Transplant Proc; 2005 Apr; 37(3):1580-2. PubMed ID: 15866679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of late conversion from C0 to C2 monitoring of microemulsified cyclosporine in pediatric living donor liver transplant recipients.
    Takatsuki M; Chen CL; Chen YS; Wang CC; Lin CC; Yang CH; Yong CC; Liu YW
    Clin Transplant; 2004 Dec; 18(6):694-9. PubMed ID: 15516246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of cyclosporine nephrotoxicity after conversion from Sandimmune to Neoral.
    Sijpkens YW; Mallat MJ; Siegert CE; Zwinderman AH; Westendorp RG; de Fijter JW; van Es LA; Paul LC
    Clin Nephrol; 2001 Feb; 55(2):149-55. PubMed ID: 11269679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin twice or three times daily dosing in pediatric transplant patients - it is not the same!
    Filler G; de Barros VR; Jagger JE; Christians U
    Pediatr Transplant; 2006 Dec; 10(8):953-6. PubMed ID: 17096765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single daily dose administration of cyclosporine in renal transplant recipients.
    Halim MA; Said T; Al-Otaibi T; Eleawa S; Al-Maged H; Gawish AE; Nair P; Al-Muzairai I; Nampoory MR; Al-Mousawi M
    Transplant Proc; 2007 May; 39(4):1225-7. PubMed ID: 17524939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine exposure and calcineurin phosphatase activity in living-donor liver transplant patients: twice daily vs. once daily dosing.
    Fukudo M; Yano I; Masuda S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
    Liver Transpl; 2006 Feb; 12(2):292-300. PubMed ID: 16447186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic profile of cyclosporine A after conversion to Sandimmun Optoral: influence on ambulatory blood pressure in renal transplant patients.
    Schwertfeger E; Keller E; Grotz W; Schollmeyer P; Rump LC
    Clin Nephrol; 1996 May; 45(5):349-51. PubMed ID: 8738670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single time point measurement by C2 or C3 is highly predictive in cyclosporine area under the curve estimation immediately after lung transplantation.
    Hangler HB; Ruttmann E; Geltner C; Bucher B; Nagiller J; Laufer G; Mueller LC
    Clin Transplant; 2008; 22(1):35-40. PubMed ID: 18217903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
    Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suitable whole blood levels 2 hours after neoral in liver transplant patients: experiences at a single center.
    Kim KH; Lee SG; Lee YJ; Park KM; Hwang S; Ahn CS; Moon DB; Ha TY; Song KW; Kim DS; Jung DH; Kim BS; Moon KM; Lee HJ; Park JI; Ryu JH
    Transplant Proc; 2006 Nov; 38(9):2971-3. PubMed ID: 17112877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
    Sibbald C; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL
    Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy.
    Taler SJ; Textor SC; Canzanello VJ; Wilson DJ; Wiesner RH; Krom RA
    Am J Hypertens; 1995 Jun; 8(6):598-605. PubMed ID: 7544983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target range maximum of cyclosporine blood concentration two hours post dose in stable liver transplant patients.
    Li J; Dahmen U; Beckebaum S; Cicinnati V; Valentin-Gamazo C; Frilling A; Malago M; Broelsch CE
    Eur J Med Res; 2006 Apr; 11(4):139-45. PubMed ID: 16720277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.